Covidien Announces Reporting Changes

DUBLIN--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced several financial reporting changes. The Specialty Chemicals business, previously reported in discontinued operations, has been reclassified to continuing operations within the Pharmaceuticals segment as a result of the Company’s decision to cease marketing the business for sale. The reclassification of this business to [...]

QIAGEN Launches Innovative Blood Dry Storage Products

QIAsafe® DNA Blood Tubes and Plates offer high DNA yield, easy transport and storage at room temperature Venlo, The Netherlands - Biobanks are the intermediary between donors and research labs to ensure the safe effective transfer of the biological information held in samples. The number of biobanks is increasing, as is the cost for power [...]

Agilent Technologies Separates Bio-Analytical Business Into Two Businesses

Agilent Technologies Separates Bio-Analytical Business Into Life Sciences and Chemical Analysis Groups - Organizational Change Fueled by Growth in Bio-Analytical Measurement SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) has announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. The change in structure reflects the growth opportunities [...]

MDS Announces Strategic Repositioning

Company Signs Agreement to Sell MDS Analytical Technologies to Danaher Corporation; Plans Substantial Return of Sale Proceeds to Shareholders; Announces Intent to Sell MDS Pharma Services TORONTO, Sept. 2 - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has entered [...]

FEI Introduces New Solution for Gunshot Residue Analysis in Forensics

GSR S50 & GSR F50 provide fully-automated analysis with dramatic improvements in speed, accuracy and affordability Hillsboro, Ore. --FEI Company (Nasdaq: FEIC), a leading provider of high-resolution imaging and analysis systems, today announced the release of two dedicated scanning electron microscopes (SEMs) and a new software package for automated analysis of gunshot residues (GSR). Forensic [...]

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

CARLSBAD, Calif.--Sep. 2, 2009-- Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture partner in the [...]

Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson’s Disease

On-line Publication of Biomarker Panel that Forms Basis for NuroPro®PD Diagnostic Test OMAHA, Neb. and HOUSTON, Tex., September 2, 2009 -- Transgenomic, Inc. (OTC BB: TBIO.OB) and Power3 Medical Products, Inc., (OTC BB:PWRM) today announced the advance on-line publication of a clinical research paper entitled “Abnormal Serum Concentrations of Proteins in Parkinson’s Disease” in the [...]

Arrayit Lands Patent for Population Scale Diagnostics in World’s Most Populous Country

China Is Expected to Be a 'Diagnostics Business Bonanza' for Arrayit SUNNYVALE, CA--(09/02/09) - Arrayit Corporation (OTC.BB:ARYC - News), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark [...]

Thermo Fisher Scientific Signs Agreement to Acquire B.R.A.H.M.S. AG

Thermo Fisher Scientific Signs Agreement to Acquire Leading Provider of Specialty In-Vitro Diagnostic Tests – B.R.A.H.M.S. AG WALTHAM, Mass.--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has signed a definitive agreement to acquire B.R.A.H.M.S. AG for €330 million (approximately $470 million USD). B.R.A.H.M.S. is a leading provider of specialty in-vitro diagnostic [...]

DHR to Acquire Life Sciences Instrumentation Businesses

DHR to Acquire Life Sciences Instrumentation Businesses from MDS Inc. and Life Technologies Corp. Washington, D.C., September 2, 2009 – Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in [...]

Access IBO on Knowledge Center